The study also demonstrated that the upregulation of Gal-9 on B-ALL cells mediated by adipocytes could potentially overcome obesity-induced chemoresistance through antibody-based therapy. Here, LGALS9 is linked to obesity due to melanocortin 4 receptor deficiency.